This article is part of the supplement: Current and new antitumor necrosis factor agents in perspective
Current and new antitumor necrosis factor agents in perspective
-
Correspondence: Ravinder N Maini r.maini@imperial.ac.uk
Arthritis Res Ther 2004, 6(Suppl 2):S1-S2 doi:10.1186/ar994
Accesses
- Last 30 days: 32 accesses
- Last 365 days: 320 accesses
- All time: 5249 accesses